Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1188

1.

Factors which predict unsuccessful mobilisation of peripheral blood progenitor cells following G-CSF alone in patients with non-Hodgkin's lymphoma.

Micallef IN, Apostolidis J, Rohatiner AZ, Wiggins C, Crawley CR, Foran JM, Leonhardt M, Bradburn M, Okukenu E, Salam A, Matthews J, Cavenagh JD, Gupta RK, Lister TA.

Hematol J. 2000;1(6):367-73.

PMID:
11920216
[PubMed - indexed for MEDLINE]
2.

High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.

Nademanee A, Sniecinski I, Schmidt GM, Dagis AC, O'Donnell MR, Snyder DS, Parker PM, Stein AS, Smith EP, Molina A, et al.

J Clin Oncol. 1994 Oct;12(10):2176-86.

PMID:
7523609
[PubMed - indexed for MEDLINE]
Free Article
3.

Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma.

Moskowitz CH, Glassman JR, Wuest D, Maslak P, Reich L, Gucciardo A, Coady-Lyons N, Zelenetz AD, Nimer SD.

Clin Cancer Res. 1998 Feb;4(2):311-6.

PMID:
9516916
[PubMed - indexed for MEDLINE]
Free Article
4.

High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma.

Haas R, Moos M, Möhle R, Döhner H, Witt B, Goldschmidt H, Murea S, Flentje M, Wannenmacher M, Hunstein W.

Bone Marrow Transplant. 1996 Feb;17(2):149-55.

PMID:
8640159
[PubMed - indexed for MEDLINE]
5.

Timing of platelet recovery is associated with adequacy of leukapheresis product yield after cyclophosphamide and G-CSF in patients with lymphoma.

Zimmerman TM, Michelson GC, Mick R, Grinblatt DL, Williams SF.

J Clin Apher. 1999;14(1):31-4.

PMID:
10355661
[PubMed - indexed for MEDLINE]
6.

Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis.

Pettengell R, Morgenstern GR, Woll PJ, Chang J, Rowlands M, Young R, Radford JA, Scarffe JH, Testa NG, Crowther D.

Blood. 1993 Dec 15;82(12):3770-7.

PMID:
7505124
[PubMed - indexed for MEDLINE]
Free Article
7.

Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma.

Negrin RS, Kusnierz-Glaz CR, Still BJ, Schriber JR, Chao NJ, Long GD, Hoyle C, Hu WW, Horning SJ, Brown BW, et al.

Blood. 1995 Jun 1;85(11):3334-41.

PMID:
7538824
[PubMed - indexed for MEDLINE]
Free Article
8.

Phase I/II trial of cure-oriented high-dose chemoradiotherapy with transplantation of CD34+ peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies. Nagoya CD34+ PBSCT Study Group.

Ogura M, Kagami Y, Suzuki R, Miura K, Uehira K, Kurokawa T, Ito T, Kinoshita T, Emi N, Morishima Y, Kodera Y, Ueda R.

Cancer Chemother Pharmacol. 1997;40 Suppl:S51-7.

PMID:
9272135
[PubMed - indexed for MEDLINE]
9.

Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF.

Engelhardt M, Winkler J, Waller C, Lange W, Mertelsmann R, Henschler R.

Bone Marrow Transplant. 1997 Mar;19(6):529-37.

PMID:
9181898
[PubMed - indexed for MEDLINE]
Free Article
10.

Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.

Carella AM, Cavaliere M, Lerma E, Ferrara R, Tedeschi L, Romanelli A, Vinci M, Pinotti G, Lambelet P, Loni C, Verdiani S, De Stefano F, Valbonesi M, Corsetti MT.

J Clin Oncol. 2000 Dec 1;18(23):3918-24.

PMID:
11099321
[PubMed - indexed for MEDLINE]
Free Article
11.

Mobilisation of peripheral blood stem cells with IVE and G-CSF improves CD34+ cell yields and engraftment in patients with non-Hodgkin's lymphomas and Hodgkin's disease.

McQuaker I, Haynes A, Stainer C, Byrne J, Russell N.

Bone Marrow Transplant. 1999 Oct;24(7):715-22.

PMID:
10516673
[PubMed - indexed for MEDLINE]
Free Article
12.

Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF.

Callera F, Cavenaghi L, de Melo CM.

Transfus Apher Sci. 2009 Apr;40(2):91-5. doi: 10.1016/j.transci.2009.01.015. Epub 2009 Feb 23.

PMID:
19233728
[PubMed - indexed for MEDLINE]
13.

Outpatient-based ifosfamide, carboplatin and etoposide (ICE) chemotherapy in transplant-eligible patients with non-Hodgkin's lymphoma and Hodgkin's disease.

Hertzberg MS, Crombie C, Benson W, Taper J, Gottlieb D, Bradstock KF.

Ann Oncol. 2003;14 Suppl 1:i11-6.

PMID:
12736225
[PubMed - indexed for MEDLINE]
Free Article
14.

Feasibility of ESHAP + G-CSF as peripheral blood hematopoietic progenitor cell mobilisation regimen in resistant and relapsed lymphoma: a single-center study of 22 patients.

Petit J, Boqué C, Cancelas JA, Sarrà J, Muñoz J, Garcia J, Grañena A.

Leuk Lymphoma. 1999 Jun;34(1-2):119-27.

PMID:
10350339
[PubMed - indexed for MEDLINE]
15.

Predictors for successful mobilization of peripheral blood progenitor cells with ESHAP + G-CSF in patients with pretreated non-Hodgkin's lymphoma.

Liu JH, Chen CC, Bai LY, Chao SC, Chang MS, Lin JS.

J Chin Med Assoc. 2008 Jun;71(6):279-85. doi: 10.1016/S1726-4901(08)70123-0.

PMID:
18567557
[PubMed - indexed for MEDLINE]
16.

Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma.

Johnston LJ, Stockerl-Goldstein KE, Hu WW, Negrin RS, Hoppe RT, Blume KG, Horning SJ.

Biol Blood Marrow Transplant. 2000;6(5A):555-62.

PMID:
11071261
[PubMed - indexed for MEDLINE]
17.

Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma.

Aurlien E, Holte H, Pharo A, Kvaløy S, Jakobsen E, Smeland EB, Kvalheim G.

Bone Marrow Transplant. 1998 May;21(9):873-8.

PMID:
9613778
[PubMed - indexed for MEDLINE]
Free Article
18.

VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group.

Santini G, Coser P, Congiu AM, Salvagno L, De Souza C, Sertoli MR, Olivieri A, Chisesi T, Rubagotti A, Truini M, Contu A, Porcellini A, Zambaldi G, Nati S, Marino G, Rizzoli V.

Haematologica. 2000 Feb;85(2):160-6.

PMID:
10681723
[PubMed - indexed for MEDLINE]
Free Article
19.

Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involvement.

Viret F, Blaise D, Bouabdallah R, Stoppa AM, Novakovitch G, Faucher C, Vey N, Camerlo J, Oziel-Taieb S, Ladaique P, Gastaut JA, Maraninchi D, Chabannon C.

Hematol Cell Ther. 1999 Feb;41(1):5-11.

PMID:
10193640
[PubMed - indexed for MEDLINE]
20.

Prediction of mobilisation failure in patients with non-Hodgkin's lymphoma.

Kuittinen T, Nousiainen T, Halonen P, Mahlamäki E, Jantunen E.

Bone Marrow Transplant. 2004 May;33(9):907-12.

PMID:
15034543
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk